Mount Sinai Leads Major NIH Study Investigating Long-COVID

New York City continues to grow as a hub for biomedical research, as one of the City’s preeminent academic medical centers, Icahn School of Medicine at Mount Sinai was named as a hub site for two cohort studies contributing to a nationwide health consortium by the National Institutes of Health (NIH) on the long-term effects of SARS-CoV-2, the virus behind COVID-19.

New York Trial Site Prominence

NIH awarded nearly $470 million to a national study population to support COVID-19 research, including the parent award to New York University (NYU) Langone Health as the RECOVER Clinical Science Core site, and multiple sub-awards to over 100 researchers at more than 30 institutions across the country, including Mount Sinai. Icahn Mount Sinai is projected to be awarded an estimated $22 million for four years as a hub site for the two cohorts. Collectively, the studies from various institutions could provide new insights into factors that include the incidence and prevalence of long COVID, the range of symptoms, underlying causes, risk factors, outcomes, and potential treatment and prevention strategies.

The Study

The NIH Researching COVID to Enhance Recovery (RECOVER) Init...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee